Affimed AFMD releases its next round of earnings this Tuesday, August 11. Here's Benzinga's essential guide to Affimed's Q2 earnings report.
Earnings and Revenue
Affimed EPS will likely be near $-0.16 while revenue will be around $5.57 million, according to analysts. In the same quarter last year, Affimed reported EPS of $-0.19 on revenue of $4.49 million. The Wall Street estimate would represent a 15.79% increase in the company's earnings. In comparison to analyst estimates in the past, here's how the company's reported EPS stacks up:
| Quarter | Q1 2020 | Q4 2020 | Q3 2019 | Q2 2019 |
|---|---|---|---|---|
| EPS Estimate | -0.14 | -0.19 | -0.17 | -0.14 |
| EPS Actual | -0.12 | -0.21 | -0.19 | -0.19 |
| Revenue Estimate | 5.93 M | 2.94 M | 4.45 M | 3.97 M |
| Revenue Actual | 5.66 M | 4.33 M | 2.29 M | 4.49 M |
Stock Performance
Over the last 52-week period, shares are up 37.87%. Given that these returns are generally positive, long-term shareholders can be content going into this earnings release.
Don't be surprised to see the stock move on comments made during its conference call. Affimed is scheduled to hold the call at 08:30:00 ET and can be accessed here: https://edge.media-server.com/mmc/p/zk8ceykt
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Date | ticker | name | Actual EPS | EPS Surprise | Actual Rev | Rev Surprise |
|---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
